Red rust mainly refers to various discolorations of stainless steel in pharmaceutical systems, consisting of metal oxides and hydroxides. It mostly occurs in pure steam system, WFI system, purified water system, etc.

The Lunar New Year has just passed when the festive atmosphere was still alive. Right at this moment, the customer service staff of Shanghai Morimatsu have engaged in the customer site and paid a return visit to collect information about the usage of the customer's equipment. During the return visit, grade II to III red rust was promptly discovered in the tank used by a company in Southwest China. The careful inspection by the customer service team determined the red rust was mainly resulted from the longer service life of the tank. In order to solve this problem as soon as possible and let customers get a better user experience, we actively communicated with the person in charge of the company, and finally completed the red rust removal service within the expected time of the customer.

Case Study

In removing red rust, Shanghai Morimatsu adopted an innovative portfolio of cleaning technology. The orderly operation of the on-site staff ensures the smooth carrying out of cleaning. Thanks to careful arrangement and efficient organization of the cleaning job, the equipment has regain a new look. In order to ensure that the customer would be satisfied with the cleaning effect and enjoy better services, the team has carried out detailed testing/verification of the equipment after finishing the task to allow it for the various conditions of high-end pharmaceutical production.

In a limited time, the Shanghai Morimatsu customer service team delivers the best job performance with a high sense of responsibility so as to achieve the most effective red rust removal. We’re detail-oriented and in pursuit of perfection. Only through thoughtful and premium services can we continue to win the trust and praise of customers.

About Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd.

Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd (Stock Code: 2155.HK) is a wholly-owned subsidiary of Morimatsu International Holdings Company Limited. Morimatsu, founded in Japan and taken root in China, has developed into a multi-national company that embraces globalization, masters core technology, and gains rich experience from project implementation in diverse fields including core equipment, process systems, and engineering solutions. The company has built advanced manufacturing base in China, established affiliates in Sweden, the United States, India, and Italy, built an efficient professional globalization team, and delivered a variety of products and services to more than 40 countries and regions.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of “predicted”, “believed”, “forecast”, “planned” and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our company management’s current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guaranties of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.